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INTRODUCTION
Evidence is accumulating that macrovascular disease is asso-
ciated with lower degrees of hyperglycemia than microvas-
cular disease. And, plasma glucose values have been associ-
ated with a risk of future diabetes, cardiovascular disease, and
total mortality (1-3). Some studies have suggested that an
fasting plasma glucose (FPG) of 5.7 mM/L is a more mean-
ingful cut off than a 2-hr cut-off of 7.8 mM/L in terms of its
sensitivity for predicting future diabetes and for defining
categories with similar (IGT) prevalences (4, 5). However,
determined FPG cutoff values suitable for predicting future
diabetes development may be population dependent. There-
fore, published findings need to be tested in populations with
different environmental and genetic backgrounds.
Asia is expected to experience the greatest increase in dia-
betes cases over the next two decades. Recently, after inves-
tigating the medical records of 54,623 Korean subjects, we
reported that FPG levels of <6.10 mM/L are closely related
to the frequencies of cardiovascular risk factors including obe-
sity, hypertension, and dyslipidemia (6). In this study, we
undertook to investigate the incidence of diabetes after a 5-
yr follow-up period versus initial FPG values in a Korean pop-
ulation, and estimated the optimal FPG value predictive of
future diabetes.
MATERIALS AND METHODS 
Samsung Medical Center is a 1,300-bed hospital and one
of the largest referral centers in Korea. In total 20,203 sub-
jects visited the Health Promotion Center at the Samsung
Medical Center for a physical check-up in 1998. Subjects with
a previous diabetes history and/or an FPG of ≥7.0 mM/L
(n=1,821) were excluded. Because almost all subjects who
visited the Health Promotion Center were middle-aged, we
included only persons aged from 35 to 65 yr (inclusive). Finally,
15,936 subjects were included in this study. A proportion of
the subjects visited the Health Promotion Center annually.
About 23% of these subjects [2,964 (2,009 men, 955 women)/
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Fasting Plasma Glucose Cutoff Value for the Prediction of Future
Diabetes Development: A Study of Middle-Aged Koreans in a Health
Promotion Center 
We determined optimal fasting plasma glucose (FPG) cutoff values predictive of
future diabetes development in a group of middle-aged Koreans who visited a health
promotion center. The medical records of 2,964 subjects, who attended the Health
Promotion Center in 1998 and 2003, were examined. Subjects were classified into
four groups according to their baseline FPG values (Group 1:FPG <5.0 mM/L; Group
2: 5.0≤FPG <5.6 mM/L; Group 3: 5.6≤FPG <6.1 mM/L; Group 4: 6.1≤FPG <7.0
mM/L). No significant difference was observed between Group 1 and Group 2 in
terms of diabetes incidence. However, incidence in Group 3 was significantly higher
than that in Group 1 [hazards ratio 4.88 (1.65-14.41), p=0.004] and the hazards
ratio in Group 4 for diabetes was 36.91 (13.11-103.61), p<0.001, versus Group 1.
Receiver operator characteristics curve analysis showed that an FPG of 5.97 mM/L
represents the lower limit and gives the best combination of sensitivity and specificity.
Our data shows that the risk of future diabetes development started to increase below
an FPG of 6.1 mM/L and suggests the importance of efforts to modify diabetes devel-
opment risk factors at lower impaired fasting glucose levels. 
Key Words : Diabetes Mellitus; Blood Glucose; Reference Values; Korea
Received : 1 November 2004
Accepted : 8 March 2005Fasting Plasma Glucose Cutoff Value and Predicting Diabetes Development 563
15,936] revisited the Health Promotion Center voluntarily
in 2003. The examination methodology used was the same
on both occasions. In 2003, after a 5-yr follow-up, subjects
being treated for diabetes or those with an FPG ≥7.0 mM/L
were classified as having newly developed diabetes. All sub-
jects were classified into four groups according to their base-
line FPG values (Group 1: FPG <5.0, n=765; Group 2: 5.0
≤FPG <5.6, n=1,244; Group 3: 5.6≤FPG <6.1, n=679;
Group 4: 6.1≤FPG <7.0 mN/L, n=276). Height and weight
were measured with subjects wearing light clothing with-
out shoes in the morning. Blood pressure was measured with
a mercury sphygmomanometer on the right arm with the
subjects in a sitting position after a 5-min rest. Body mass
indexes (BMI) were calculated as weight in kilograms divid-
ed by height squared in meters. This study was approved by
the Internal Review Board of Samsung Medical Center.
Analytical methods 
Plasma glucose was measured in duplicate using an auto-
analyzer (Hitachi, Tokyo, Japan) and the hexokinase method.
The interassay coefficient of variation was 1.6%. Total choles-
terol, HDL-cholesterol, LDL-cholesterol, and triglycerides
were also measured using an autoanalyzer (Hitachi, Tokyo,
Japan).
Statistics 
Data are expressed as means±SD. Cox regression analyses
were performed to determine the hazards ratios of diabetes
development for each group, after controlling for age, gender,
BMI, change of BMI, parental history of diabetes, systolic
blood pressure, diastolic blood pressure, serum LDL-choles-
terol, triglyceride, and HDL-cholesterol. To determine the
optimal FPG value for the prediction of future diabetes, receiver
operator characteristics curve analysis was performed. Statis-
tical analyses were performed using SPSS/PC
+ (SPSS, Inc.,
Chicago, IL, U.S.A.). Differences were considered statistically
significant at p<0.05.
RESULTS
The baseline characteristics of the study subjects are pre-
sented in Table 1. Because this study involved subjects who
voluntarily attended Health Promotion Center for both base-
line and follow-up examinations, we compared the character-
istics of subjects that only received a baseline examination
with those that received baseline and follow-up examinations.
The total follow-up participation rate was 22.8% (28.1% in
men, 13.4% in women). Follow-up participation rates in each
group were 16.1% in group 1, 18.9% in group 2, 20.5% in
group 3, and 20.9% in group 4. As presented in Table 1, FPG
values, ages and the proportion of male subjects in baseline
and follow-up groups, were significantly higher than in the
baseline only group. Person-year diabetes incidence according
to the baseline FPG categories were 0.1% in Group 1, 0.2%
in Group 2, 0.7% in Group 3, and 5.5% in Group 4. 
In a previous study of subjects who attended our Health
Promotion Center, age, a male sex, a parental history of dia-
betes, BMI, systolic and diastolic blood pressure, serum LDL-
cholesterol, triglyceride and HDL-cholesterol were found to
be positively associated with the presence of diabetes (7). There-
fore, we tried to investigate the relationship FPG baseline
values and incidence of newly developed diabetes after con-
trolling for these variables. By Cox regression analyses after
controlling for age, gender, BMI, change of BMI, parental
history of diabetes, systolic blood pressure, diastolic blood
pressure, serum LDL-cholesterol, triglyceride, and HDL-
cholesterol, no significant difference was found between Group
1 and Group 2 in terms of the incidence of diabetes. How-
ever, the incidence of diabetes in Group 3 was significantly
Baseline only
Group 1 Group 2 Group 3 Group 4 Total
Baseline and follow-up
Group 1 Group 2 Group 3 Group 4 Total
No. (%) 3,976 (23.7) 5,321 (41.0) 2,630 (20.3) 1,045 (8.1) 12,972 765 (25.8) 1,244 (42.0) 679 (22.9) 276 (9.3) 2,964
FPG (mM/L) 4.68±0.23 5.24±0.16 5.76±0.16 6.39±0.24 5.27±0.54 4.69±0.23 5.24±0.16 5.76±0.16 6.40±0.22 5.32±0.54*
Age (yr) 46.8±7.9 48.3±8.0 49.7±7.9 51.4±7.8 48.4±8.0 47.7±7.3* 48.6±6.8 49.8±6.8 50.7±7.2 48.8±7.0*
Male sex (%) 42.2 54.1 68.3 76.4 44.9 51.0* 68.0* 79.4* 84.8* 67.8*
Baseline BMI (kg/m
2) 22.7±2.7 23.4±2.7 24.1±2.8 24.6±2.7 23.4±2.8 22.7±2.6 23.4±2.5 24.2±2.5 24.6±2.2 23.5±2.6
Baseline BMI  19.5 26.2 35.2 42.6 27.4 18.0 24.7 37.6 40.2 27.4
≥25 kg/m
2 (%)
Parental history of  7.6 8.2 10.3 11.0 8.6 6.0 7.1 8.5 9.4 7.4
�
diabetes (%)
Years of follow-up (%) 4.88±0.36 4.93±0.35 4.97±0.31 4.97±0.35 4.97±0.35
Person-year incidence  0.1 0.2 0.7 5.5 3.8
of diabetes (%)
Table 1. Baseline characteristics according to baseline FPG
� p<0.05, *p<0.01 compared to the baseline only group by the t-test or 
2 test. Group 1: FPG <5.0; Group 2: 5.0 ≤FPG <5.6; Group 3: 5.6≤FPG <6.1;
Group 4: 6.1≤FPG <7.0 mM/L. FPG, fasting plasma glucose; BMI, body mass index.564 D.-J. Kim, N.-H. Cho, J.-H. Noh, et al.
higher than in Group 1 [hazards ratio 4.88 (1.65-14.41), p=
0.004] and the hazards ratio for diabetes in Group 4 was 36.91
(13.11-103.61) compared to Group 1 (p<0.001) (Table 2).
In a subgroup analysis of men, the incidence of diabetes in
Group 3 was found to be significantly higher than that in
Group 1. However in women, no significant difference was
found between Group 1 and Group 3. 
Receiver operator characteristics curve analysis was per-
formed to investigate the optimal value of FPG for predict-
ing future diabetes (area under the curve 0.872, p<0.001)
(Fig. 1), and identified a lower limit FPG limit of 5.97 mM/L
as the fasting category that gave the best combination of sen-
sitivity and specificity. In subgroup analyses, the correspond-
ing optimal values were 5.97 mM/L for men and 5.86 mM/L
for women. Overall sensitivity and specificity at an FPG of
5.97 mM/L were 0.74 and 0.90, respectively. The compara-
ble figures at 6.10 mM/L were 0.63 and 0.93, respectively,
and those at 5.6 mM/L were 0.83 and 0.75.
DISCUSSION
To the best of our knowledge, this is the first study to attempt
to identify an FPG cutoff value for the prediction of future
diabetes development in Korean subjects. Recently, the Amer-
ican Diabetes Association (ADA) expert committee on the
diagnosis and classification of diabetes mellitus suggested
that the cut-off for impaired fasting glucose should be reduced
from 6.1 mM/L to 5.6 mM/L. They reported that the FPG
value, by receiver operator characteristics curve analysis, closest
to the ideals of 100% sensitivity and 100% specificity over
the glycemic range of 4.5-7.0 mM/L was 5.7 mM/L in a Dutch
population, 5.4 mM/L in a Pima Indian population, 5.4 mM/L
in a Mauritian population, and 5.2 mM/L in a San Antonio
population (8). 
However, in the present study when a baseline FPG of <5.6
mM/L was investigated no difference was observed in the inci-
dence of diabetes versus baseline by Cox regression analysis.
However, subjects with an FPG ≥5.6 mM/L and <6.1 mM/L
showed significantly higher diabetes incidence after a 5-yr
follow-up period than those with an FPG of <5.6 mM/L. Our
data suggest that the incidence of diabetes development start-
ed to increase before an FPG of 6.10 mM/L (the lower limit
value originally proposed for impaired fasting glucose) in our
Korean population. By subgroup analyses according to gen-
der, we found a significant difference of diabetes incidence
using an FPG cut off of 5.6 mM/L in men, but no significant
difference in women. In the present study, men were older,
more obese, had higher blood pressures, poorer lipid profiles,
and higher FPGs than women (data not shown). We consider
that the explanation for the observed difference between men
and women is provided by their markedly different participa-
tion rates at follow-up (28.1% in men, 13.4% in women,
p<0.001). In our study, the optimal FPG cut off value for
predicting future diabetes development using receiver oper-
ator characteristics curve analysis was 5.9 mM/L, which is
somewhat higher than that reported by other studies. We are
unable do explain this discrepancy, though it may be due to
Model 1
Total
Exp(B) 
(95% CI)
p
Men
Exp(B) 
(95% CI)
p
Women
Exp(B) 
(95% CI)
p
Model 2
Total
Exp(B) 
(95% CI)
p
Men
Exp(B) 
(95% CI)
p
Women
Exp(B) 
(95% CI)
p
vs group1 Group 2 1.46  NS 1.61  NS 1.32  NS 1.48  NS 1.69  NS 1.42  NS
(0.46-4.59) (0.18-14.40) (0.34-5.19) (0.47-4.66) (0.19-15.19) (0.36-5.67)
Group 3 4.88 0.004 9.23 0.032 2.02  NS 4.77 0.005 9.50  0.030 1.91  NS
(1.65-14.41) (1.22-70.02) (0.49-8.37) (1.60-14.15) (1.25-72.24) (0.45-8.21)
Group 4 36.91 <0.001 74.83  <0.001 16.12  <0.001 34.57  <0.001 76.02 <0.001 15.46  <0.001
(13.11-103.61) (10.3-543.02) (4.43-58.63) (12.18-98.10) (10.42-544.51) (4.08-58.61)
Table 2. Hazard ratio of diabetes development according to baseline FPG by multivariate Cox regression analyses
Group 1: FPG <5.0; Group 2: 5.0 ≤FPG <5.6; Group 3: 5.6 ≤FPG <6.1; Group 4: 6.1 ≤FPG <7.0 mM/L; NS, not significant. The dependent variable
was the development of diabetes. Independent variables in model 1 were age, gender, BMI, change of BMI, and a parental history of diabetes, and
in model 2 were systolic blood pressure, diastolic blood pressure, serum LDL-cholesterol, triglyceride, HDL-cholesterol and the variables of model 1.
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Fig. 1. Optimal value of FPG for diabetes prediction by ROC analy-
sis. Area under the curve=0.872, p<0.001. Sensitivity and speci-
ficity at a FPG of 5.97 mM/L were 0.74 and 0.90, respectively, and
those at 6.10 mM/L were 0.63 and 0.93, respectively. 
Optimal point; 5.97 mmol/L
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ethnic differences. In view of our lack of oral glucose tolerance
test data, we cannot conclusively state that the optimal FPG
cut off value in Korean subjects is higher than in other ethnic
groups. However, it is noteworthy that in low risk popula-
tions like the Dutch and Korean populations that the opti-
mal FPG cut-off values for separating high and low risk sub-
jects are higher than in high risk populations like the Pima
Indians, Mexican Americans, and others. 
The most important limitation of the present study is the
incompleteness of the diabetes diagnoses, because of a lack
of oral glucose tolerance test (OGTT) data. This incomplete-
ness is a potential source of result distortion, because it is
expected that some subjects with minor FPG abnormalities
at baseline developed diabetic OGTT, but not overt diabetes
five years later. However, comparable reports on the preva-
lence of diabetes using WHO criteria or ADA criteria in the
Korean population (7.1% by the WHO criteria, 7.7% by the
ADA criteria after adjusting to the standard world popula-
tion of Segi), reduces this concern (9). Another study in the
Korean population reported that the use of FPG data without
OGTT data to diagnose diabetes might fail to detect a some
diabetics, especially in elderly subjects (10). In the present
study, subjects older than 65 yr were excluded. Another major
limitation of our study is that it was not a population-based
study. The present study included only middle-aged persons,
and these attended a health promotion center for an annual
physical check-up. Thus they may have had more health con-
cerns and health problems than the general population. Actu-
ally, in the present study, those who participated in the base-
line and follow-up studies were older and had higher FPG
values than those who submitted for the baseline study only.
Therefore, our findings should be confirmed by a population-
based prospective study. 
In conclusion, the data obtained during the present study
shows that risk of future diabetes starts to increase from below
an FPG level of 6.1 mmol/L, and thus, suggests the impor-
tance of our making a concentrated effort to reduce the risk
factors of diabetes early during the development of fasting
glucose impairment.
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